Clinical Research Directory

Inclusion Criteria: 1. Signed written informed consent. 2. Male or female ≥18 years. 3. Patients selected to be treated with Connettivina Bio. 4. Patients with wound of the following etiology: first and second degree burns; surgical wounds; vascular ulcers; metabolic ulcers; pressure ulcers. 5. Patients followed on an outpatient or home basis. 6. Wound area ≥ 10 cm2 and ≤ 100 cm2 Exclusion Criteria: 1. Patients \< 18 years. 2. Patients with acute or chronic infected lesions. 3. Hospitalized patients. 4. Patients with acute or chronic lesions at high risk of infection, presenting at least one of the following criteria: * Stalled wound, without any clinical sign of healing progression * Immune system disorders * Protein-energy malnutrition * Alcohol, smoking and drug abuse * Conditions associated with hypoxia and/or poor tissue perfusion * Corticosteroid, cytotoxic or immunosuppressive therapy. 5. Subjects unable to understand informed consent or having a high probability of non-compliance with the study procedures and or non-completion of the study according to investigator's judgement.